Al Hammadi profits up 18% to SAR 303.3M in 2023; Q4 at SAR 65.2M

Al Hammadi Holding Co.’s net profit jumped 18% to SAR 303.3 million in 2023, compared to SAR 257.3 million in the year before.

Financials (M)

Item	2022	2023	Change‬
Revenues	1,122.40	1,176.76	4.8 %
Gross Income	419.67	433.14	3.2 %
Operating Income	262.81	313.16	19.2 %
Net Income	257.34	303.33	17.9 %
Average Shares	160.00	160.00	-
EPS (Riyals)	1.61	1.90	17.9 %

The profit growth was due to the net profit margin soaring to 25.8% in 2023, from 22.9% in 2022. Further, Al Hammadi’s top line grew 4.8% year-on-year (YoY) for the same year, lifted by increased revenues from the medical services and the pharmaceutical products segments within the company’s hospitals.

In Q4 2023, the company’s bottom line slumped by 11% to SAR 65.2 million, compared to SAR 73.17 million in the year-ago period.

On a quarterly basis, net income fell 12.9% from SAR 74.87 million in the third quarter of 2023.

Current Quarter Comparison (M)

Compared With The

Item	Q4 2022	Q4 2023	Change‬
Revenues	342.64	303.68	(11.4 %)
Gross Income	131.00	106.45	(18.7 %)
Operating Income	75.30	59.10	(21.5 %)
Net Income	73.17	65.19	(10.9 %)
Average Shares	160.00	160.00	-
EPS (Riyals)	0.46	0.41	(10.9 %)

Item	Q3 2023	Q4 2023	Change‬
Revenues	297.83	303.68	2.0 %
Gross Income	113.08	106.45	(5.9 %)
Operating Income	79.30	59.10	(25.5 %)
Net Income	74.87	65.19	(12.9 %)
Average Shares	160.00	160.00	-
EPS (Riyals)	0.47	0.41	(12.9 %)

Total shareholders’ equity, no minority interest, widened to SAR 1.84 billion by the end of Dec. 31, 2023, from SAR 1.71 billion in the year-earlier period.

View More Financial Results

View other reports

Share Price

Al Hammadi Holding (ALHAMMADI)

	Current
Market Cap (M Riyal)	6,328.00
Enterprise Value (EV) (M)	6,089.92
Shares Outstanding ((M))	160.00
EPS ( Riyal) (TTM)	2.04
Book Value (BV) ( Riyal)	12.11
Par Value ( Riyal)	10.00
Adjusted P/E (Last12)	23.92
P/E (TTM)	19.40
Price/book	3.26
Return on Average Assets (%) (TTM)	12.5
Return on Average Equity (%) (TTM)	17.3

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
Q1 2014	122.04	16.4 %	54.71	15.6 %	35.96	19.5 %
Q2 2014	121.66	11.8 %	53.68	17.1 %	35.77	57.3 %
Q3 2014	108.83	13.1 %	44.74	21.5 %	24.77	30.3 %
Q4 2014	129.43	4.3 %	55.99	1.5 %	34.52	0.5 %
2014	481.96	11.0 %	209.11	12.9 %	130.95	16.8 %
Q1 2015	129.48	6.1 %	50.64	(7.4 %)	33.35	(7.3 %)
Q2 2015	137.36	12.9 %	63.56	18.4 %	37.91	6.0 %
Q3 2015	136.80	25.7 %	57.97	29.6 %	31.92	28.8 %
Q4 2015	157.70	21.8 %	68.06	21.6 %	40.39	17.0 %
2015	561.33	16.5 %	240.24	14.9 %	143.57	9.6 %
Q1 2016	144.16	11.3 %	54.75	8.1 %	26.66	(20.0 %)
Q2 2016	138.08	0.5 %	57.56	(9.5 %)	27.63	(27.1 %)
Q3 2016	141.35	3.3 %	56.48	(2.6 %)	25.97	(18.6 %)
Q4 2016	182.65	15.8 %	73.35	7.8 %	18.58	(54.0 %)
2016	606.24	8.0 %	242.13	0.8 %	98.81	(31.2 %)
Q1 2017	180.23	25.0 %	62.02	13.3 %	33.61	26.0 %
Q2 2017	176.71	28.0 %	58.16	1.0 %	32.88	19.0 %
Q3 2017	163.01	15.3 %	53.91	(4.5 %)	26.46	1.9 %
Q4 2017	188.69	3.3 %	65.08	(11.3 %)	33.93	82.6 %
2017	708.62	16.9 %	239.16	(1.2 %)	126.88	28.4 %
Q1 2018	200.67	11.3 %	66.84	7.8 %	38.29	13.9 %
Q2 2018	214.49	21.4 %	53.28	(8.4 %)	28.26	(14.0 %)
Q3 2018	250.40	53.6 %	64.92	20.4 %	31.19	17.9 %
Q4 2018	228.04	20.9 %	65.32	0.4 %	29.53	(13.0 %)
2018	893.60	26.1 %	250.36	4.7 %	127.27	0.3 %
Q1 2019	229.68	14.5 %	65.60	(1.9 %)	27.20	(29.0 %)
Q2 2019	253.83	18.3 %	71.08	33.4 %	30.95	9.5 %
Q3 2019	220.00	(12.1 %)	62.22	(4.2 %)	31.85	2.1 %
Q4 2019	270.55	18.6 %	83.72	28.2 %	39.60	34.1 %
2019	974.06	9.0 %	282.62	12.9 %	129.59	1.8 %
Q1 2020	206.69	(10.0 %)	66.48	1.3 %	33.84	24.4 %
Q2 2020	244.30	(3.8 %)	90.81	27.7 %	53.15	71.8 %
Q3 2020	207.85	(5.5 %)	77.59	24.7 %	43.13	35.4 %
Q4 2020	230.47	(14.8 %)	68.48	(18.2 %)	19.33	(51.2 %)
2020	764.06	(21.6 %)	252.83	(10.5 %)	103.91	(19.8 %)
Q1 2021	226.29	9.5 %	87.41	31.5 %	22.69	(32.9 %)
Q2 2021	223.90	(8.4 %)	79.96	(11.9 %)	33.63	(36.7 %)
Q3 2021	219.92	5.8 %	88.16	13.6 %	49.65	15.1 %
Q4 2021	281.78	22.3 %	108.53	58.5 %	19.27	(0.3 %)
2021	951.89	24.6 %	364.05	44.0 %	125.24	20.5 %
Q1 2022	250.89	10.9 %	96.08	9.9 %	65.16	187.1 %
Q2 2022	281.94	25.9 %	109.09	36.4 %	70.02	108.2 %
Q3 2022	246.92	12.3 %	83.50	(5.3 %)	52.33	5.4 %
Q4 2022	342.64	21.6 %	131.00	20.7 %	75.30	290.7 %
2022	1,122.40	17.9 %	419.67	15.3 %	262.81	109.8 %
Q1 2023	298.60	19.0 %	120.20	25.1 %	87.24	33.9 %
Q2 2023	276.66	(1.9 %)	93.42	(14.4 %)	87.53	25.0 %
Q3 2023	297.83	20.6 %	113.08	35.4 %	79.30	51.5 %
Q4 2023	303.68	(11.4 %)	106.45	(18.7 %)	59.10	(21.5 %)
2023	1,176.76	4.8 %	433.14	3.2 %	313.16	19.2 %

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
2014	481.96	11.0 %	209.11	12.9 %	130.95	16.8 %
2015	561.33	16.5 %	240.24	14.9 %	143.57	9.6 %
2016	606.24	8.0 %	242.13	0.8 %	98.81	(31.2 %)
2017	708.62	16.9 %	239.16	(1.2 %)	126.88	28.4 %
2018	893.60	26.1 %	250.36	4.7 %	127.27	0.3 %
2019	974.06	9.0 %	282.62	12.9 %	129.59	1.8 %
2020	764.06	(21.6 %)	252.83	(10.5 %)	103.91	(19.8 %)
2021	951.89	24.6 %	364.05	44.0 %	125.24	20.5 %
2022	1,122.40	17.9 %	419.67	15.3 %	262.81	109.8 %
2023	1,176.76	4.8 %	433.14	3.2 %	313.16	19.2 %

Profit Performance (Million)

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
Q1 2014	34.23	14.7 %	0.21	-	34.23	0.21
Q2 2014	35.60	18.4 %	0.22	-	35.60	0.22
Q3 2014	25.42	38.7 %	0.16	-	25.42	0.16
Q4 2014	33.71	1.2 %	0.21	-	33.71	0.21
2014	128.95	15.6 %	0.81	-	128.95	0.81
Q1 2015	41.01	19.8 %	0.26	9.80	31.21	0.20
Q2 2015	36.89	3.6 %	0.23	-	36.89	0.23
Q3 2015	27.69	8.9 %	0.17	-	27.69	0.17
Q4 2015	35.75	6.0 %	0.22	-	35.75	0.22
2015	141.33	9.6 %	0.88	9.80	131.53	0.82
Q1 2016	21.14	(48.5 %)	0.13	-	21.14	0.13
Q2 2016	20.63	(44.1 %)	0.13	-	20.63	0.13
Q3 2016	20.73	(25.1 %)	0.13	-	20.73	0.13
Q4 2016	10.48	(70.7 %)	0.07	-	10.48	0.07
2016	72.96	(48.4 %)	0.46	-	72.96	0.46
Q1 2017	27.97	32.3 %	0.17	-	27.97	0.17
Q2 2017	25.66	24.4 %	0.16	-	25.66	0.16
Q3 2017	23.59	13.8 %	0.15	-	23.59	0.15
Q4 2017	30.76	193.4 %	0.19	-	30.76	0.19
2017	107.97	48.0 %	0.67	-	107.97	0.67
Q1 2018	30.88	10.4 %	0.19	-	30.88	0.19
Q2 2018	19.93	(22.3 %)	0.12	-	19.93	0.12
Q3 2018	21.31	(9.7 %)	0.13	-	21.31	0.13
Q4 2018	17.70	(42.5 %)	0.11	-	17.70	0.11
2018	89.81	(16.8 %)	0.56	-	89.81	0.56
Q1 2019	24.17	(21.7 %)	0.15	-	24.17	0.15
Q2 2019	20.01	0.4 %	0.13	-	20.01	0.13
Q3 2019	21.17	(0.6 %)	0.13	-	21.17	0.13
Q4 2019	27.65	56.2 %	0.17	-	27.65	0.17
2019	93.00	3.5 %	0.58	-	93.00	0.58
Q1 2020	24.94	3.2 %	0.16	-	24.94	0.16
Q2 2020	39.10	95.4 %	0.24	(4.99)	44.10	0.28
Q3 2020	36.57	72.7 %	0.23	-	36.57	0.23
Q4 2020	30.21	9.3 %	0.19	-	30.21	0.19
2020	130.83	40.7 %	0.82	(4.99)	135.82	0.85
Q1 2021	35.54	42.5 %	0.22	-	35.54	0.22
Q2 2021	40.31	3.1 %	0.25	-	40.31	0.25
Q3 2021	3.58	(90.2 %)	0.02	(39.18)	42.76	0.27
Q4 2021	10.67	(64.7 %)	0.07	(9.69)	20.36	0.13
2021	90.09	(31.1 %)	0.56	(48.87)	138.96	0.87
Q1 2022	61.96	74.4 %	0.39	-	61.96	0.39
Q2 2022	65.10	61.5 %	0.41	-	65.10	0.41
Q3 2022	57.11	1494.9 %	0.36	-	57.11	0.36
Q4 2022	73.17	586.0 %	0.46	-	73.17	0.46
2022	257.34	185.6 %	1.61	-	257.34	1.61
Q1 2023	81.42	31.4 %	0.51	-	81.42	0.51
Q2 2023	81.85	25.7 %	0.51	-	81.85	0.51
Q3 2023	74.87	31.1 %	0.47	-	74.87	0.47
Q4 2023	65.19	(10.9 %)	0.41	6.46	58.73	0.37
2023	303.33	17.9 %	1.90	6.46	296.87	1.86

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
2014	128.95	15.6 %	0.81	-	128.95	0.81
2015	141.33	9.6 %	0.88	9.80	131.53	0.82
2016	72.96	(48.4 %)	0.46	-	72.96	0.46
2017	107.97	48.0 %	0.67	-	107.97	0.67
2018	89.81	(16.8 %)	0.56	-	89.81	0.56
2019	93.00	3.5 %	0.58	-	93.00	0.58
2020	130.83	40.7 %	0.82	(4.99)	135.82	0.85
2021	90.09	(31.1 %)	0.56	(48.87)	138.96	0.87
2022	257.34	185.6 %	1.61	-	257.34	1.61
2023	303.33	17.9 %	1.90	6.46	296.87	1.86

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2014	42.66 %	27.85 %	24.35 %
Q2 2014	43.18 %	29.90 %	26.17 %
Q3 2014	43.70 %	30.34 %	26.97 %
Q4 2014	43.39 %	30.09 %	26.75 %
2014	43.39 %	30.07 %	26.75 %
Q1 2015	41.90 %	29.13 %	25.73 %
Q2 2015	42.55 %	28.68 %	25.19 %
Q3 2015	42.80 %	29.71 %	24.29 %
Q4 2015	42.80 %	31.06 %	23.43 %
2015	42.80 %	31.06 %	23.43 %
Q1 2016	42.42 %	30.79 %	21.09 %
Q2 2016	41.32 %	30.64 %	18.24 %
Q3 2016	40.74 %	29.96 %	16.90 %
Q4 2016	39.94 %	25.11 %	12.04 %
2016	39.94 %	25.10 %	12.03 %
Q1 2017	38.83 %	24.74 %	12.43 %
Q2 2017	36.71 %	24.09 %	12.46 %
Q3 2017	35.22 %	23.41 %	12.48 %
Q4 2017	33.75 %	25.39 %	15.24 %
2017	33.75 %	25.39 %	15.24 %
Q1 2018	33.46 %	26.03 %	15.21 %
Q2 2018	31.18 %	25.45 %	13.71 %
Q3 2018	29.28 %	24.60 %	12.04 %
Q4 2018	28.02 %	24.14 %	10.05 %
2018	28.02 %	24.14 %	10.05 %
Q1 2019	27.00 %	22.96 %	9.01 %
Q2 2019	27.75 %	22.56 %	8.65 %
Q3 2019	28.36 %	23.59 %	8.92 %
Q4 2019	29.01 %	23.82 %	9.55 %
2019	29.01 %	23.82 %	9.55 %
Q1 2020	29.81 %	25.12 %	9.86 %
Q2 2020	32.21 %	27.70 %	12.52 %
Q3 2020	34.28 %	29.29 %	14.34 %
Q4 2020	34.11 %	28.49 %	15.27 %
2020	33.09 %	27.20 %	17.78 %
Q1 2021	35.68 %	26.87 %	16.11 %
Q2 2021	35.28 %	25.58 %	16.05 %
Q3 2021	35.98 %	26.21 %	16.52 %
Q4 2021	38.24 %	24.65 %	14.60 %
2021	38.24 %	24.65 %	14.60 %
Q1 2022	38.17 %	28.20 %	16.94 %
Q2 2022	38.84 %	29.87 %	18.38 %
Q3 2022	37.42 %	29.18 %	19.27 %
Q4 2022	37.39 %	32.36 %	22.93 %
2022	37.39 %	32.36 %	22.93 %
Q1 2023	37.93 %	32.83 %	23.66 %
Q2 2023	36.75 %	34.47 %	25.20 %
Q3 2023	37.65 %	35.21 %	25.61 %
Q4 2023	36.81 %	35.12 %	25.23 %
2023	36.81 %	35.12 %	25.23 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2014	43.39 %	30.07 %	26.75 %
2015	42.80 %	31.06 %	23.43 %
2016	39.94 %	25.10 %	12.03 %
2017	33.75 %	25.39 %	15.24 %
2018	28.02 %	24.14 %	10.05 %
2019	29.01 %	23.82 %	9.55 %
2020	33.09 %	27.20 %	17.78 %
2021	38.24 %	24.65 %	14.60 %
2022	37.39 %	32.36 %	22.93 %
2023	36.81 %	35.12 %	25.23 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2014	44.83 %	32.21 %	28.04 %
Q2 2014	44.12 %	32.25 %	29.26 %
Q3 2014	41.11 %	26.05 %	23.36 %
Q4 2014	43.26 %	29.45 %	26.04 %
Q1 2015	39.11 %	28.49 %	24.10 %
Q2 2015	46.28 %	30.21 %	26.86 %
Q3 2015	42.37 %	30.62 %	20.24 %
Q4 2015	43.16 %	34.31 %	22.67 %
Q1 2016	37.98 %	27.65 %	14.66 %
Q2 2016	41.68 %	29.60 %	14.94 %
Q3 2016	39.95 %	27.83 %	14.67 %
Q4 2016	40.16 %	17.59 %	5.74 %
Q1 2017	34.41 %	25.82 %	15.52 %
Q2 2017	32.91 %	26.06 %	14.52 %
Q3 2017	33.07 %	24.41 %	14.47 %
Q4 2017	34.49 %	25.21 %	16.30 %
Q1 2018	33.31 %	28.10 %	15.39 %
Q2 2018	24.84 %	23.98 %	9.29 %
Q3 2018	25.93 %	21.86 %	8.51 %
Q4 2018	28.65 %	23.30 %	7.76 %
Q1 2019	28.56 %	22.87 %	10.52 %
Q2 2019	28.00 %	22.30 %	7.88 %
Q3 2019	28.28 %	26.14 %	9.62 %
Q4 2019	30.94 %	24.16 %	10.22 %
Q1 2020	32.17 %	28.77 %	12.07 %
Q2 2020	37.17 %	32.12 %	18.05 %
Q3 2020	37.33 %	33.16 %	17.59 %
Q4 2020	29.72 %	20.18 %	13.11 %
Q1 2021	38.63 %	22.24 %	15.70 %
Q2 2021	35.71 %	27.50 %	18.00 %
Q3 2021	40.09 %	35.31 %	19.45 %
Q4 2021	38.51 %	16.01 %	7.22 %
Q1 2022	38.29 %	36.27 %	24.70 %
Q2 2022	38.69 %	33.79 %	23.09 %
Q3 2022	33.82 %	31.75 %	23.13 %
Q4 2022	38.23 %	28.77 %	21.35 %
Q1 2023	40.25 %	37.48 %	27.27 %
Q2 2023	33.77 %	40.70 %	29.58 %
Q3 2023	37.97 %	35.24 %	25.14 %
Q4 2023	35.05 %	27.59 %	19.34 %

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
Q1 2014	160.00	0.72	0.69	3.87
Q2 2014	160.00	0.76	0.76	7.88
Q3 2014	160.00	0.80	0.80	8.04
Q4 2014	160.00	0.81	0.81	8.25
Q1 2015	160.00	0.85	0.79	8.51
Q2 2015	160.00	0.86	0.80	8.27
Q3 2015	160.00	0.87	0.81	8.44
Q4 2015	160.00	0.88	0.82	8.66
Q1 2016	160.00	0.76	0.76	8.80
Q2 2016	160.00	0.66	0.66	8.37
Q3 2016	160.00	0.61	0.61	8.50
Q4 2016	160.00	0.46	0.46	8.56
Q1 2017	160.00	0.50	0.50	8.75
Q2 2017	160.00	0.53	0.53	8.89
Q3 2017	160.00	0.55	0.55	9.04
Q4 2017	160.00	0.67	0.67	8.67
Q1 2018	160.00	0.69	0.69	8.85
Q2 2018	160.00	0.66	0.66	8.98
Q3 2018	160.00	0.64	0.64	9.11
Q4 2018	160.00	0.56	0.56	9.24
Q1 2019	160.00	0.52	0.52	9.40
Q2 2019	160.00	0.52	0.52	9.51
Q3 2019	160.00	0.52	0.52	9.63
Q4 2019	160.00	0.58	0.58	9.79
Q1 2020	160.00	0.59	0.59	9.95
Q2 2020	160.00	0.71	0.74	10.21
Q3 2020	160.00	0.80	0.83	10.42
Q4 2020	160.00	0.82	0.85	10.62
Q1 2021	160.00	0.88	0.92	10.47
Q2 2021	160.00	0.89	0.89	10.73
Q3 2021	160.00	0.69	0.93	10.75
Q4 2021	160.00	0.56	0.87	10.37
Q1 2022	160.00	0.73	1.03	10.47
Q2 2022	160.00	0.88	1.19	10.56
Q3 2022	160.00	1.22	1.28	10.61
Q4 2022	160.00	1.61	1.61	10.69
Q1 2023	160.00	1.73	1.73	10.85
Q2 2023	160.00	1.83	1.83	11.01
Q3 2023	160.00	1.95	1.95	11.49
Q4 2023	160.00	1.90	1.86	11.53

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
2014	160.00	0.81	0.81	8.25
2015	160.00	0.88	0.82	8.66
2016	160.00	0.46	0.46	8.56
2017	160.00	0.67	0.67	8.67
2018	160.00	0.56	0.56	9.24
2019	160.00	0.58	0.58	9.79
2020	160.00	0.82	0.85	10.62
2021	160.00	0.56	0.87	10.37
2022	160.00	1.61	1.61	10.69
2023	160.00	1.90	1.86	11.53

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
Q1 2014	-	-	-
Q2 2014	-	-	-
Q3 2014	51.42	51.42	5.14
Q4 2014	48.92	48.92	4.78
Q1 2015	51.53	55.54	5.14
Q2 2015	54.13	58.30	5.61
Q3 2015	44.33	47.69	4.57
Q4 2015	41.63	44.73	4.24
Q1 2016	36.41	36.41	3.14
Q2 2016	45.86	45.86	3.60
Q3 2016	36.32	36.32	2.62
Q4 2016	68.31	68.31	3.64
Q1 2017	61.37	61.37	3.50
Q2 2017	58.51	58.51	3.49
Q3 2017	47.94	47.94	2.91
Q4 2017	41.25	41.25	3.21
Q1 2018	39.28	39.28	3.07
Q2 2018	37.68	37.68	2.76
Q3 2018	32.21	32.21	2.27
Q4 2018	33.55	33.55	2.04
Q1 2019	35.91	35.91	1.98
Q2 2019	30.97	30.97	1.69
Q3 2019	32.09	32.09	1.73
Q4 2019	27.16	27.16	1.61
Q1 2020	24.17	24.17	1.42
Q2 2020	23.40	22.41	1.62
Q3 2020	27.10	26.08	2.08
Q4 2020	26.52	25.54	2.04
Q1 2021	24.66	23.82	2.08
Q2 2021	33.33	33.33	2.77
Q3 2021	42.10	31.02	2.68
Q4 2021	53.70	34.82	2.92
Q1 2022	46.73	32.92	3.25
Q2 2022	41.33	30.71	3.46
Q3 2022	36.83	35.09	4.23
Q4 2022	24.93	24.93	3.75
Q1 2023	28.18	28.18	4.49
Q2 2023	33.19	33.19	5.53
Q3 2023	26.78	26.78	4.53
Q4 2023	31.33	32.01	5.15

Period	P/E	Adjusted P/E	Price/book
2014	48.92	48.92	4.78
2015	41.63	44.73	4.24
2016	68.34	68.34	3.64
2017	41.25	41.25	3.21
2018	33.55	33.55	2.04
2019	27.16	27.16	1.61
2020	26.52	25.54	2.04
2021	53.70	34.82	2.92
2022	24.93	24.93	3.75
2023	31.33	32.01	5.15

Business Segments (Million)

Compared With The

Period	healthy services and other	Pharmaceutical sales revenue - Pharmacies
Q1 2017	150.74	29.49
Q2 2017	147.45	29.26
Q3 2017	136.70	26.31
Q4 2017	155.95	32.73
Q1 2018	140.85	59.82
Q2 2018	143.64	71.39
Q3 2018	140.83	109.03
Q4 2018	154.81	73.23
Q1 2019	146.91	82.77
Q2 2019	151.05	102.78
Q3 2019	149.00	71.00
Q4 2019	177.92	92.62
Q1 2020	152.48	54.21
Q2 2020	192.83	51.46
Q3 2020	47.34	35.26
Q4 2020	185.43	45.04
Q1 2021	168.82	57.47
Q2 2021	163.87	60.02
Q3 2021	180.27	39.64
Q4 2021	224.93	56.85
Q1 2022	195.39	55.50
Q2 2022	232.25	49.69
Q3 2022	201.88	45.04
Q4 2022	241.22	101.43
Q1 2023	238.75	59.85
Q2 2023	217.85	58.80
Q3 2023	242.76	55.06
Q4 2023	251.51	52.17

Period	healthy services and other	Pharmaceutical sales revenue - Pharmacies
2014	360.30	121.61
2015	451.60	109.71
2016	552.40	89.11
2017	590.84	117.78
2018	580.13	313.47
2019	624.88	349.18
2020	578.09	185.97
2021	737.90	213.99
2022	870.74	251.65
2023	950.87	225.89

Analysts Estimates (Million)

Item	Q4 2023 (e)	Q4 2023 (a)	Change‬
Average	89.99	65.19	(27.6 %)

Estimates vs Actual (Million)

Item	Q4 2023 (e)	Q4 2023 (a)	Change
Al Rajhi Capital	78.00	65.19	(16.4) %
SNB Capital	82.40	65.19	(20.9) %
U-Capital	89.30	65.19	(27.0) %
AlJazira Capital	91.00	65.19	(28.4) %
OSOOL AND BAKHEET	99.22	65.19	(34.3) %
Hermes	100.00	65.19	(34.8) %

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Al Hammadi profits up 18% to SAR 303.3M in 2023; Q4 at SAR 65.2M

Financials (M)

Current Quarter Comparison (M)

View other reports

Share Price

Al Hammadi Holding (ALHAMMADI)

Financial Ratios

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2023 Q4

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Popular Links

Quick Links

About Us

Join Us

Follow Us

Al Hammadi profits up 18% to SAR 303.3M in 2023; Q4 at SAR 65.2M

Financials (M)

Current Quarter Comparison (M)

View other reports

Share Price

Al Hammadi Holding (ALHAMMADI)

Financial Ratios

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) Q4 2023

Revenue by Business Segment (Latest) 2023 Q4

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Popular Links

Quick Links

About Us

Join Us

Follow Us

Business Segments (Million)